NewEdge Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.61M Sell
9,794
-13
-0.1% -$3.52K 0.01% 967
2025
Q4
$2.46M Buy
9,807
+684
+7% +$182K 0.01% 966
2025
Q3
$2.62M Buy
9,123
+1,419
+18% +$380K 0.01% 881
2025
Q2
$2.02M Sell
7,704
-842
-10% -$205K 0.01% 930
2025
Q1
$1.99M Buy
8,546
+1,721
+25% +$418K 0.01% 870
2024
Q4
$1.57M Buy
6,825
+6,538
+2,278% +$1.5M 0.01% 942
2024
Q3
$64.2K Hold
287
﹤0.01% 2354
2024
Q2
$58.4K Sell
287
-967
-77% -$197K ﹤0.01% 2297
2024
Q1
$274K Buy
1,254
+979
+356% +$216K ﹤0.01% 1687
2023
Q4
$62.5K Buy
275
+85
+45% +$17.9K ﹤0.01% 2144
2023
Q3
$38.2K Sell
190
-35
-16% -$7.38K ﹤0.01% 2176
2023
Q2
$46.5K Sell
225
-4,411
-95% -$856K ﹤0.01% 2104
2023
Q1
$914K Buy
4,636
+4,115
+790% +$847K 0.01% 820
2022
Q4
$60.8K Buy
+521
New +$102K ﹤0.01% 1641
2022
Q1
Sell
-1,571
Closed -$424K 1413
2021
Q4
$424K Buy
1,571
+654
+71% +$162K 0.01% 1154
2021
Q3
$222K Buy
+917
New +$231K 0.01% 1016
2021
Q2
Sell
-2,449
Closed -$537K 1173
2021
Q1
$537K Buy
+2,449
New +$491K 0.02% 644
2017
Q3
Sell
-335
Closed -$43.6K 784
2017
Q2
$43.6K Buy
+335
New +$41K 0.01% 556

Other funds holding LH

NewEdge Advisors's LH Position: Q1 2026 in Review

NewEdge Advisors reduced its Labcorp (LH) stake by 0.13% in Q1 2026, selling an estimated $3.52K and leaving 9,794 shares worth $2.61M. The position accounts for 0.01% of the portfolio, ranked #967.

NewEdge Advisors first reported a position in LH in Q2 2017 and has held it in 18 quarters since. The position peaked at $2.62M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • NewEdge Advisors held 9,794 shares of Labcorp worth $2.61M as of Q1 2026.
  • NewEdge Advisors sold 13 Labcorp shares in Q1 2026, an estimated $3.52K.
  • Labcorp made up 0.01% of NewEdge Advisors's portfolio in Q1 2026, its #967 holding.
  • NewEdge Advisors first reported a position in Labcorp in Q2 2017 and has held it in 18 quarters since.
  • NewEdge Advisors's Labcorp position peaked at $2.62M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.